Medical diagnostics company Oxford Immunotec has appointed Frank Vandeputte vice president, sales and marketing. He was formerly VP, Europe for …

Amanda Stuart will later this week join the ABPI as its new head of government affairs, with a remit to …
Cephalon has promoted Alain Aragues to executive vice president and president of Cephalon Europe. He joined Cephalon in 2002 to …

UK pharma industry association the ABPI has named GSK’s UK general manager Simon Jose its next president. He will take …
Norwegian cancer drug development company Clavis Pharma has appointed Olav Hellebø as its new chief executive. He joins the company …

Amsterdam-based technology company Avantium has appointed Gunnar Staaf as chief executive of its pharma business in preparation for spinning it …

Cephalon’s executive vice president of worldwide pharmaceutical operations Robert Roche is leaving the company at the beginning of February to …

Charles Bancroft has been appointed acting chief financial officer at Bristol-Myers Squibb, replacing Jean-Marc Huet who left the company at …
Sanofi-Aventis has appointed Han Regenauer vice president, consumer healthcare, Europe and global development. In his new role he will report …

AstraZeneca’s Bruno Angelici has been appointed Chevalier dans l`Ordre National de la Légion d`honneur in the French New Year honours …

Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …

Marketing intelligence agency Synovate has appointed Steve Lowery group head, custom healthcare, in the UK. Lowery joins Synovate from Kantar …

GlaxoSmithKline chief executive Andrew Witty has been appointed president of EFPIA.He previously served as vice-president of the European industry association for two years and takes …
Lilly’s senior vice president and chief financial officer Derica Rice has taken on an expanded role. He becomes executive vice …
Serge Weinberg has joined the board of directors at Sanofi-Aventis, replacing Gunter Thielen, who has resigned for personal reasons. The …